• Press Release

Joseph D Buxbaum PhD Elected to National Academy of Medicine

  • New York
  • (October 19, 2015)

Joseph D. Buxbaum, PhD, Professor and Vice Chair for Research in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai, has been elected as one of 70 new members to the prestigious National Academy of Medicine (NAM), formerly known as The Institute of Medicine (IOM). A world-renowned molecular geneticist and neurobiologist, he is also the Director of the Seaver Autism Center for Research and Treatment at Mount Sinai.

“Election to the National Academy of Medicine is considered one of the highest honors in medicine,” says Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai.  “Dr. Buxbaum’s election is a notable achievement and well-deserved recognition of his leadership and important contributions to uncovering the genetic and molecular basis of autism spectrum disorder.”

Dr. Buxbaum’s research focuses on using techniques of molecular genetics and neuroscience to identify and characterize genes that contribute to autism susceptibility. His laboratory has identified common and rare genetic variants that underlie autism and has developed model systems in which novel therapeutics can be tested. This work has led to novel clinical trials in rare genetic disorders associated with autism. As the founder and co-leader of the Autism Sequencing Consortium, he heads an international group of scientists who share autism samples, data and ideas in order to accelerate our understanding of the causes of and treatments for autism.

Recruited in part to establish a molecular genetics program in autism, Dr. Buxbaum joined Mount Sinai in 1997 as Director of Molecular Genetics at the Seaver Autism Center.  He took over Directorship of the Center in 2008.  Dr. Buxbaum also leads Mount Sinai’s Laboratory of Molecular Neuropsychiatry, which has taken the findings of the causes of neuropsychiatric disorders and translated them into animal models where therapeutic approaches can be evaluated.

Dr. Buxbaum earned his PhD from the Weizmann Institute of Science in Rehovot, Israel, and completed a post-doctoral fellowship in the Laboratory of Molecular and Cellular Neuroscience at the Rockefeller University.  He is the author of more than 200 publications, and he is co-editor in chief of the journal Molecular Autism.

New members to the NAM are elected by current active members through a selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care, and public health. Established in 1970 by the National Academy of Sciences, the National Academy of Medicine is a national resource that provides independent, objective analysis and advice on health issues.

About the Seaver Autism Center for Research and Treatment at Mount Sinai
The Seaver Autism Center for Research and Treatment at Mount Sinai conducts progressive research studies aimed at understanding the multiple causes of autism spectrum disorder (ASD). The multidisciplinary team is comprised of experts in the fields of genetics, molecular biology, model systems, neuroimaging, and experimental therapeutics who are dedicated to discovering the biological causes of ASD. The Center strives to develop innovative diagnostics and treatments for integration into the provision of personalized, comprehensive assessment and care for people with ASD. The Seaver Autism Center was founded through the generous support of the Beatrice and Samuel A. Seaver Foundation. For more information, visit www.seaverautismcenter.org.

About The Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services from community-based facilities to tertiary and quaternary care.

The System includes approximately 6,100 primary and specialty care physicians; 12 minority-owned free-standing ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. Seven departments at The Mount Sinai Hospital and one at the New York Eye and Ear Infirmary (NYEE) ranked nationally in the top 25 in the 2015-2016 “Best Hospitals” issue of U.S. News & World Report. Mount Sinai’s Kravis Children’s Hospital also is ranked in seven out of ten pediatric specialties by U.S. News & World Report.     

For more information, visit http://www.mountsinaihealth.org/ or find Mount Sinai on Facebook, Twitter and YouTube.

# # #


About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest integrated delivery system encompassing seven hospital campuses, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The System includes approximately 6,600 primary and specialty care physicians; 10 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 13 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 18 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery, and in the top 50 in six other specialties in the 2018-2019 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology and 44th for Ear, Nose, and Throat, while Mount Sinai Beth Israel, Mount Sinai St. Luke's and Mount Sinai West are ranked regionally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.